Compare Enphase Energy Inc (ENPH) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enphase Energy Inc vs Johnson & Johnson — how do they compare? Enphase Energy Inc trades at $32.81 (market cap $4.35B), while Johnson & Johnson trades at $261.44 (market cap $618.09B). The key difference: Johnson & Johnson is far larger — about 142.1× Enphase Energy Inc's market cap, and Johnson & Johnson pays a 2.09% dividend while Enphase Energy Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Enphase Energy Inc for 72 Days and Johnson & Johnson for 129 Days on average.
| ENPH | JNJ | |
|---|---|---|
Market Cap | $4.35B | $618.09B |
Volume | 5,068,595 | 6,050,983 |
Sector | Energy | Health |
52-Week High | $72.33 | $278.43 |
52-Week Low | $26.12 | $186.00 |
Typical Hold Time | 72 Days | 129 Days |
Enterprise Value | $3.99B | $646.37B |
Dividend Yield | — | 2.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enphase Energy (ENPH) trades at $32.91, down 1.76% on the day, with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported Q4 2025 earnings beat but missed Q1 and Q2 2026 expectations, with revenue declining from $2.3B in 2023 to $1.47B in 2025. Recent developments include IQ Meter Collar approval by 80 utilities and solid-state transformer advancements for AI data centers, providing potential growth catalysts amid challenging solar market conditions.
The outlook remains cautious with analyst consensus at Buy (41.82%) but near-term headwinds from high borrowing costs impacting solar financing. The stock trades at a P/E of 32.58, above sector averages, while maintaining solid gross margins of 46.95%. Key risks include solar industry volatility and execution challenges, though institutional ownership remains substantial with upside to the $43.18 consensus target.
Johnson & Johnson (JNJ) trades at $256.48, down 0.76% on the day, with the stock showing mixed technical signals amid a bearish overall trend. The company maintains strong fundamentals with $94.19B in 2025 revenue, 21.48% net income margin, and consistent earnings beats in recent quarters. Recent analyst coverage shows 52.5% buy ratings with a $286.53 consensus price target, while technical indicators point to key support at $248 and resistance at $258.
JNJ presents a compelling long-term investment case with robust profitability, diversified healthcare portfolio, and dividend stability, though near-term headwinds include patent expirations and competitive pressures. The stock's current valuation at 29.75 P/E appears reasonable given strong cash flow generation and pipeline innovation, with upside potential to analyst targets if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enphase Energy Inc
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
